Addus HomeCare (NASDAQ:ADUS – Get Free Report) was upgraded by investment analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a research report issued on Tuesday, Zacks reports.
Several other research firms have also recently issued reports on ADUS. UBS Group increased their price objective on Addus HomeCare from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, November 5th. Bank of America lowered shares of Addus HomeCare from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $140.00 to $125.00 in a research report on Monday, September 14th. TD Cowen upped their price target on shares of Addus HomeCare from $131.00 to $145.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Barclays increased their price target on shares of Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a report on Wednesday, November 4th. Finally, Weiss Ratings upgraded shares of Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, September 24th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $134.70.
View Our Latest Research Report on ADUS
Addus HomeCare Stock Performance
Shares of ADUS stock opened at $125.49 on Tuesday. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.02. The stock has a 50 day simple moving average of $118.19 and a 200-day simple moving average of $107.10. The company has a market cap of $2.34 billion, a price-to-earnings ratio of 20.91, a price-to-earnings-growth ratio of 1.66 and a beta of 0.75. Addus HomeCare has a 12-month low of $87.95 and a 12-month high of $131.59.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.79 by $0.04. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. The firm had revenue of $387.74 million for the quarter, compared to the consensus estimate of $388.72 million. During the same period in the previous year, the business earned $1.56 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. On average, equities analysts forecast that Addus HomeCare will post 6.41 EPS for the current year.
Insider Buying and Selling at Addus HomeCare
In related news, EVP Brian Poff sold 6,644 shares of the company’s stock in a transaction that occurred on Friday, November 6th. The stock was sold at an average price of $124.72, for a total value of $828,639.68. Following the sale, the executive vice president owned 57,048 shares in the company, valued at $7,115,026.56. This represents a 10.43% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Cliff Donald Blessing sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, November 6th. The shares were sold at an average price of $124.18, for a total value of $248,360.00. Following the completion of the transaction, the executive vice president directly owned 10,183 shares of the company’s stock, valued at $1,264,524.94. The trade was a 16.42% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 131,655 shares of company stock worth $16,275,572. Corporate insiders own 4.10% of the company’s stock.
Institutional Trading of Addus HomeCare
Institutional investors have recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in Addus HomeCare in the second quarter valued at $344,153,000. Bank of America Corp DE acquired a new position in shares of Addus HomeCare during the 2nd quarter worth $35,527,000. TimesSquare Capital Management LLC purchased a new stake in shares of Addus HomeCare in the 2nd quarter worth about $31,502,000. Punch & Associates Investment Management Inc. purchased a new stake in shares of Addus HomeCare in the 2nd quarter worth about $20,911,000. Finally, William Blair Investment Management LLC purchased a new stake in shares of Addus HomeCare in the 2nd quarter worth about $17,703,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.
Key Addus HomeCare News
Investors following ADUS have been watching these news items:
- Neutral Sentiment: Addus plans to participate in the 2026 Stephens Annual Investment Conference. The announcement offers investor access but provides no new operating or financial guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
- Neutral Sentiment: A report claims short interest was zero shares, despite describing it as a large increase. The conflicting wording makes the short-interest update difficult to interpret.
- Negative Sentiment: Several executives sold shares on Nov. 6, and CEO R. Allison sold 98,958 shares on Nov. 9 for about $12.2 million, reducing his stake by 35.08%. Five executive vice presidents also sold a combined 32,697 shares. The volume of insider selling may weigh on investor sentiment, though sales alone do not establish a negative view of the company. CEO sale filing Article: EVP share sale
Addus HomeCare Company Profile
Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.
See Also
- Five stocks we like better than Addus HomeCare
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
